<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93831">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01883388</url>
  </required_header>
  <id_info>
    <org_study_id>RAM-NOVEL-211-2012</org_study_id>
    <nct_id>NCT01883388</nct_id>
  </id_info>
  <brief_title>NovellusDx Cancer Early Detection Blood Test- Clinical Trial</brief_title>
  <official_title>Assessing the Ability of An Innovative Screening Method To Identify Proteomic Changes In Cancer Patients- Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NovellusDx</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NovellusDx</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      NovellusDx early detection test is a simple to perform blood test, which identifies the
      deregulated signaling pathways within the patient tumor based on protein secretion to the
      blood, thus enabling early stage disease signature detection. The investigators' current
      clinical trial is focused on proving the main feature of NovellusDx's Early Detection Test-
      discriminating between cancer patients and healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants with a significant cancer fingerprint as measured by NovellusDX Cancer Early Detection test</measure>
    <time_frame>3.5 years</time_frame>
    <description>NovellusDX Cancer Early Detection test will identify participants with significant cancer fingerprint based on tumor protein secretion to the blood circulation in sick subjects.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Lung Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy subjects and subjects with primary / relapsed lung cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects ages 18 and above ICF obtain

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yishai Ofran, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam MC. Haematology Department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rambam MC</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <lastchanged_date>October 6, 2014</lastchanged_date>
  <firstreceived_date>June 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lung Cancer</keyword>
  <keyword>blood sample</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
